Development code · Small Molecule
ABX-002
ABX-002 is a development code for Elunetirom (ABX-002), developed by Autobahn Therapeutics, Inc..
- Status
- Phase 2 for Bipolar depression
- Mechanism
- TRbeta Agonist
- Developer
- Autobahn Therapeutics, Inc.
Programs
- Elunetirom (ABX-002) for Bipolar depressionPhase 2Active
- Elunetirom (ABX-002) for Major depressive disorderPhase 2Recruiting
Also known as
- MA-JD21
- LL-340001
- elunetirom
- 2156649-32-8
- 2-[3,5-dichloro-4-[(4-hydroxy-3-propan-2-ylphenyl)methyl]phenoxy]-N-methylacetamide